Retifanlimab

Generic name: Retifanlimab
Brand names: Zynyz
Dosage form: intravenous solution (dlwr 500 mg/20 mL)
Drug class: Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)

Usage of Retifanlimab

Retifanlimab is used to treat a type of skin cancer called Merkel cell carcinoma in adults, when the cancer has spread to other parts of the body (metastatic) or returned.

Retifanlimab may also be used for purposes not listed in this medication guide.

Retifanlimab side effects

Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.

Some side effects may occur during the injection. Tell your medical caregiver if you feel dizzy, nauseated, light-headed, itchy, sweaty, or have a headache, chest tightness, back pain, trouble breathing, or swelling in your face.

Retifanlimab may cause serious side effects. Call your doctor at once if you have:

cough, shortness of breath, chest pain;

irregular heartbeat;

confusion, drowsiness, memory problems, changes in mood or behavior, stiff neck, problems with balance, tingling or numbness in your arms or legs;

vision changes, sensitivity to light, eye pain;

severe muscle pain or weakness, muscle cramps;

bruising;

severe stomach pain or tenderness, diarrhea, bloody or tarry stools;

blistering or peeling of the skin, rash, itching;

genital area, mouth, nose, or throat sores or ulcers;

flu-like symptoms;

feeling sick or uneasy, with pain or swelling near your transplanted organ;

low red blood cells (anemia)--pale skin, tiredness, feeling light-headed or short of breath, cold hands and feet;

liver problems--loss of appetite, nausea, vomiting, stomach pain (upper right side), tiredness, itching, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);

kidney problems--little or no urination, red or pink urine, swelling in your feet or ankles; or

signs of a hormonal disorder--unusual headaches, vision problems, feeling light-headed or very tired, rapid heartbeats, mood or behavior changes, hoarse or deepened voice, increased hunger or thirst, increased urination, constipation, hair loss, sweating, feeling cold, muscle pain, weight gain, or weight loss.

Your treatment with retifanlimab may be delayed or permanently discontinued if you have certain side effects.

Common side effects of retifanlimab may include:

tiredness;

itching, rash;

fever;

muscle and bone pain; or

nausea, diarrhea.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Retifanlimab

Tell your doctor if you have or have ever had:

immune system problems such as ulcerative colitis, Crohn's disease, or lupus;

a nervous system condition, such as myasthenia gravis or Guillain-Barré syndrome;

received an organ transplant;

received or plan to receive a stem cell transplant that uses donor stem cells; or

received radiation treatment to your chest area.

You may need to have a negative pregnancy test before starting this treatment.

May harm an unborn baby. Do not use if you are pregnant. Use effective birth control while using retifanlimab and for at least 4 months after your last dose. Tell your doctor if you become pregnant.

Do not breastfeed while using retifanlimab, and for at least 4 months after your last dose.

Relate drugs

How to use Retifanlimab

Usual Adult Dose for Merkel Cell Carcinoma:

Dose: 500 mg IV every 4 weeks -Administer as IV infusion over 30 minutes until disease progression, unacceptable toxicity, or up to 24 monthsComments:This indication is approved under accelerated approval based on tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.Use: For the treatment of adult patients with metastatic or recurrent locally advanced Merkel cell carcinoma (MCC)

Warnings

Call your doctor at once if you have symptoms such as: cough, flu symptoms, muscle pain or weakness, vision changes, chest pain, trouble breathing, severe stomach pain or diarrhea, rash, swelling in your ankles, increased or decreased urination, blood in your urine or stools, weight changes, hair loss, dark urine, or jaundice (yellowing of your skin or eyes).

What other drugs will affect Retifanlimab

Other drugs may affect retifanlimab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.